Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 24:12:1083501.
doi: 10.3389/fcimb.2022.1083501. eCollection 2022.

Editorial: Developing therapeutics for antimicrobial resistant pathogens

Raja Veerapandian  1 , Parveez Ahamed Abdul Azees  2 , Thiruselvam Viswanathan  3 , Bennett Tochukwu Amaechi  2 , Govindsamy Vediyappan  4
Affiliations
Editorial

Editorial: Developing therapeutics for antimicrobial resistant pathogens

Raja Veerapandian et al. Front Cell Infect Microbiol. .
No abstract available

Keywords: anti-biofilm drugs; anti-virulence drugs; antibiotic- antibody combination therapy; drugs; in silico drug design; nanotechnology; repurposed drugs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Different therapeutic strategies for combating antimicrobial resistant pathogens. AMR pathogens depicted in the figure is based on the Centers for Disease Control and Prevention (CDC), 2019 antibiotic resistance threats report, which categorized the AMR pathogens into urgent threats, serious threats, concerning threats and watch list https://www.cdc.gov/drugresistance/biggest-threats.html. Various therapeutic approaches like plant- derived antimicrobials, antimicrobial peptides (AMPs), Nanomaterials, Phage therapy, small compound library screening, Drug repurposing, Vaccines, and Antibiotic-Antibody conjugates (AAC) are currently available to fight against AMR pathogens.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Developing therapeutics for antimicrobial resistant pathogens

References

    1. Centers for Disease Control and Prevention (2019) 2019 AR threats report. Available at: https://www.cdc.gov/drugresistance/biggest-threats.html (Accessed October 17, 2022).
    1. de Kraker M. E., Stewardson A. J., Harbarth S. (2016). Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med. 13 (11), e1002184. doi: 10.1371/journal.pmed.1002184 - DOI - PMC - PubMed
    1. Fisher M. C., Alastruey-Izquierdo A., Berman J., Bicanic T., Bignell E. M., Bowyer P., et al. . (2022). Tackling the emerging threat of antifungal resistance to human health. Nat. Rev. Microbiol. 20 (9), 557–571. doi: 10.1038/s41579-022-00720-1 - DOI - PMC - PubMed
    1. Fisher M. C., Hawkins N. J., Sanglard D., Gurr S. J. (2018). Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 360 (6390), 739–742. doi: 10.1126/science.aap7999 - DOI - PubMed
    1. Hartmann T. (2007). From waste products to ecochemicals: fifty years research of plant secondary metabolism. Phytochemistry. 68 (22-24), 2831–2846. doi: 10.1016/j.phytochem.2007.09.017 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources